Contract Insights

Did you miss any of our blog posts from March?  Don’t worry; we have outlined each of them for you.  Stay up-to-date with industry topics, real-world case studies, and contract management and procurement best practices by reading CobbleStone’s latest content.

As the US begins to successfully mitigate the effects of the ongoing COVID 19 pandemic, it would be nearly impossible to overstate how vital it has been for manufacturers to consistently improve and optimize the COVID vaccine supply chain and for the US government to enlist the aid of the best possible suppliers.  As the current rate of daily doses continues to grow - and we celebrate how successful supply chain management has begun to save the day - let's look at some tips to maintain future-minded supply chain management processes moving forward.

Government contract management can be divided into three overarching phases: procurement and acquisition planning, the sourcing and award, and post-award contract administration.  The first two phases typically enjoy the most time, attentiveness, and financial investment.  However, the neglect of the third stage - post-award management - as a tertiary duty can leave your organization unsupported and en route toward needless compliance violations, increased risk variables, and missed opportunities.  It could be argued that the post award contract process is the most essential stage for your government organization, but it has notoriously been abandoned to insufficient visibility and a lack of allocated resources.  Read this article to learn how to face the challenges of post award contract management head on with an actionable post award contract management software solution.

This blog post was updated on March 3, 2021.

Pharmaceutical and life sciences organizations have a lot on their plate.  Unfortunately, many organizations lack an efficient process to handle a myriad of contracts, clinical trials, promotions, supplies/goods, regulations, and compliance standards.  Consequently, these organizations may leave themselves unprotected from potential increased risk, delays, compliance violations, wasted time, and squandered revenue.  Here’s how to improve life sciences and pharmaceutical contract management with accelerated contracting and compliance management.